When to discontinue oral contraceptives.
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced; D002273:Carcinogens / Q000009:adverse effects; D002278:Carcinoma in Situ / Q000139:chemically induced / Q000517:prevention & control; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003273:Contraceptive Devices; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D003863:Depression / Q000139:chemically induced; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D007889:Leiomyoma / Q000473:pathology; D008099:Liver / Q000187:drug effects; D010859:Pigmentation Disorders / Q000139:chemically induced; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D014594:Uterine Neoplasms / Q000473:pathology; D014652:Vascular Diseases / Q000139:chemically induced
D002273:Carcinogens; D003276:Contraceptives, Oral; D004967:Estrogens; D011374:Progesterone